Acute development of multiple keratoacanthomas and squamous cell carcinomas after treatment with infliximab

Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent

Joseph Keane, Sharon K. Gershon, Robert P. Wise et al. · New England Journal of Medicine · 2001 · 3.7K citations · Full text

Medicine, Immunology, Pharmacotherapy +16

Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

Ravinder N. Maini, E. William St. Clair, Ferdinand C. Breedveld et al. · The Lancet · 1999 · 2.4K citations

Medicine, Pharmacology, Pharmacotherapy +17

Tumor necrosis factor antagonist therapy and lymphoma development: Twenty‐six cases reported to the Food and Drug Administration

S Brown, Mark H. Greene, Sharon K. Gershon et al. · Arthritis & Rheumatism · 2002 · 661 citations

Life Sciences, Immunology, Pharmacotherapy +11

Life‐threatening histoplasmosis complicating immunotherapy with tumor necrosis factor α antagonists infliximab and etanercept

Jong‐Hoon Lee, Nancy R. Slifman, Sharon K. Gershon et al. · Arthritis & Rheumatism · 2002 · 448 citations

Medicine, Immunology, Pharmacotherapy +10

Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation

Sylvie Euvrard, Jean Kanitakis, Claire Pouteil‐Noble et al. · Journal of the American Academy of Dermatology · 1995 · 255 citations

Medicine, Dermatology, Oncology +16